Expression of arginyl-tRNA synthetase in rats with focal cerebral ischemia

Abstract

Aminoacyl-tRNA syntheses (AARS) can catalyze the adenosine triphosphate (ATP)-dependent acylation of their cognate tRNA(s) with a specific amino acid. They can be seen as an index to reflect the energy metabolic rate of ischemic brain cells in ischemic penumbra. This study examined the relationship between arginyl-tRNA synthetase (ArgRS), one of the AARS, and cerebral ischemia in rats. The model of middle cerebral artery occlusion (MCAO) was established in rats. The expression levels of ArgRS protein and mRNA were detected in rat brain tissues at different time points following MCAO by Western blotting and RT-PCR, respectively. The results showed that the MCAO model was successfully established. Western blotting and RT-PCR analysis revealed that the ArgRS protein and mRNA were expressed in brain cells in both ischemic and normal penumbra tissues. The expression levels of ArgRS protein and mRNA peaked at 6 h after MCAO and decreased gradually. At 24 h, the expression levels of ArgRs protein and mRNA in ischemic penumbral tissues were lower than those in normal tissues. The expression levels of ArgRS mRNA and protein in ischemic penumbra varied with ischemic time, suggesting that the energy metabolism of brain cells in penumbra changed dynamically after ischemia to ensure the endogenous self-protection of the body. The brain oxygen supply should be improved as soon as possible, especially within 6–12 h after ischemia, so as to meet the demand for energy metabolism in ischemic penumbra and make sure the cell structure remains stable.

Keywords

stroke / cerebral ischemia / arginyl-tRNA synthetase / gene expression / protein expression

References

[1] AndersonLL, MaoXR, ScottBA, et al.. Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases. Science, 2009, 323(5914): 630-633

[2] StoreyKB, StoreyJM. Metabolic rate depression in animals: transcriptional and translational controls. Biol Rev Camb Philos Soc, 2004, 79(1): 207-233

[3] NathanielTI. Brain-regulated metabolic suppression during hibernation: a neuroprotective mechanism for perinatal hypoxia-ischemia. Int J Stroke, 2008, 3(2): 98-104

[4] AslamiH, JuffermansNP. Induction of a hypometabolic state during critical illness-a new concept in the ICU?. Neth J Med, 2010, 68(5): 190-198

[5] ZhaoR, GaoK, YuCH. Review and prospect of energy metabolism research of brain. Ke Xue (Chinese), 2009, 61(3): 11-14

[6] RossAP, ChristianSL, ZhaoHW, et al.. Persistent tolerance to oxygen and nutrient deprivation and N-methyl-D-aspartate in cultured hippocampal slices from hibernating Arctic ground squirrel. J Cereb Blood Flow Metab, 2006, 26(9): 1148-1156

[7] KamphuisW, DijkF, van SoestS, et al.. Global gene expression profiling of ischemic preconditioning in the rat retina. Mol Vis, 2007, 13: 1020-1030

[8] KatoH, KanellopoulosGK, MatsuoS, et al.. Protection of rat spinal cord from ischemia with dextrorphan and cycloheximide: effects on necrosis and apoptosis. J Thorac Cardiovasc Surg, 1997, 114(4): 609-618

[9] SniderBJ, DuC, WeiL, et al.. Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Res, 2001, 917: 147-157

[10] LiangCL, YangLC, LuK, et al.. Neuroprotective synergy of N-methyl-D-aspartate receptor antagonist (MK801) and protein synthesis inhibitor (cycloheximide) on spinal cord ischemia-reperfusion injury in rats. J Neurotrauma, 2003, 20(2): 195-206

[11] JiaJ, JinYX. Macromolecular network and new function of aminoacyl-tRNA synthetases. Prog Bio-chem Biophys, 2004, 31(4): 291-295

[12] Candelario-JalilE. Injury and repair mechanisms in ischemic stroke: Considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs, 2009, 10(7): 644-654